Sensei Biotherapeutics, Inc. (SNSE) NASDAQ

9.65

-1.025(-9.61%)

Updated at January 02 04:00PM

Currency In USD

Valuation

Market Cap246.15M
Enterprise Value240M
P/E Ratio-0.5
PEG Ratio0.01
Price/Sales Ratio22.36
Price/Book Ratio0.53
Enterprise/Revenue6.66
Enterprise/EBITDA-0.15

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-44.37
Operating Margin-47.07

Management Effectiveness

Return On Assets-0.87
Return On Equity-0.8

Income Statement

Revenue0
Revenue/Share0.43
Gross Profit-551,000
EBITDA-29.52M
Net Income-30.16M
Diluted EPS-1.2

Balance Sheet

Total Cash25.04M
Total Cash/Share19.85
Total Debt2.02M
Total Debt/Equity0.09
Current Ratio5.81
Book Value Per Share18.24

Price History

52-Week Change-8.4
52-Week High18.35
52-Week Low5
Moving Average 50 Days9.09
Moving Average 200 Days8.43

Statistics

Average Volume88,159
Shares Outstanding1.26M
% Held by Institutions7.59

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJune 17, 2025